H19 and neoplasm: For clinical translation, CICRlncRNAs could be detected in liquid biopsies (e.g., plasma exosomal RNA via RT–qPCR) or tumor tissues (via RNA in situ hybridization), similar to established lncRNA biomarkers such as H19 in GC (78).